SCHEMBL5318865

SCHEMBL5318865

Nc1cnc(-c2cccc(Cl)c2)cn1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.50
MAOB P27338 1/20 0.50
DHFR P00374 1/20 0.49
IDO1 P14902 2/20 0.49
MAP4K4 O95819 5/20 0.48
HSD17B1 P14061 1/20 0.47
HSD17B2 P37059 1/20 0.47
TDO2 P48775 1/20 0.46
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45
NUDT1 P36639 1/20 0.45
ALOX5AP P20292 3/20 0.45
FEN1 P39748 3/20 0.45
BACE1 P56817 1/20 0.45
ATR Q13535 1/20 0.45
JAK2 O60674 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11683554 0.81 KDM1A (0.53) KDM1AMAOBDHFRIDO1MAP4K4
SCHEMBL16826157 0.79 KDM1A (0.50) KDM1AIDO1MAP4K4HSD17B1HSD17B2
SCHEMBL2614946 0.79 KDM1A (0.50) KDM1AMAOBIDO1HSD17B1HSD17B2
SCHEMBL2134773 0.79 KDM1A (0.61) KDM1AMAOBDHFRIDO1MAP4K4
SCHEMBL2323103 0.79 MAP4K4 (0.57) IDO1MAP4K4HSD17B1HSD17B2ALOX5AP
SCHEMBL6820766 0.79 HSD17B1 (0.79) KDM1AMAP4K4HSD17B1HSD17B2ADORA1
SCHEMBL29818187 0.79 MAP4K4 (0.57) IDO1MAP4K4HSD17B1HSD17B2ALOX5AP
SCHEMBL2609392 0.78 IDO1 (0.45) KDM1AMAOBDHFRIDO1MAP4K4
SCHEMBL2322762 0.77 SLC6A2 (0.49) KDM1AMAOBMAP4K4ALOX5APFEN1
SCHEMBL934072 0.77 FEN1 (0.62) ADORA2AADORA1ALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1343503-B1 HETEROARYL UREA NEUROPEPTIDE Y Y5 RECEPTOR ANTAGONISTS SCHERING CORP (US) 2008-11-12 EP disclosed
WO-2007096764-A2 BICYCLIC HETEROARYL DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS GLENMARK PHARMACEUTICALS S.A. (US) 2007-08-30 WO disclosed